Research on the Impact of Drug Volume-based Procurement Policy on Hospital Cost Management: A Case Study of Aier Eye Hospital Group

Yongshang Qu

doi:10.47297/wspbdsWSP2752-630527.20250503

PDF
Export
Share
Collection
Album

Research on the Impact of Drug Volume-based Procurement Policy on Hospital Cost Management: A Case Study of Aier Eye Hospital Group

Volume 5, Issue 3

Views: 0 Downloads: 0

Research on the Impact of Drug Volume-based Procurement Policy on Hospital Cost Management: A Case Study of Aier Eye Hospital Group
Research on the Impact of Drug Volume-based Procurement Policy on Hospital Cost Management: A Case Study of Aier Eye Hospital Group
West China School of Clinical Medicine, Sichuan University, Chengdu, Sichuan, 610065, China
Vol. 5, Issue 3, Pages: 134-137(2025)
Published：30 September 2025
DOI：10.47297/wspbdsWSP2752-630527.20250503
Accepted：

Scan QR Code

Qu Yongshang.Research on the Impact of Drug Volume-based Procurement Policy on Hospital Cost Management: A Case Study of Aier Eye Hospital Group[J].Biomedical Data Science,2025,05(03):134-137.
DOI：

Qu Yongshang.Research on the Impact of Drug Volume-based Procurement Policy on Hospital Cost Management: A Case Study of Aier Eye Hospital Group[J].Biomedical Data Science,2025,05(03):134-137. DOI： 10.47297/wspbdsWSP2752-630527.20250503.

摘要

Abstract

With the acceleration and expansion of the "volume-based procurement" policy

the prices of drugs and medical consumables in China have dropped significantly

effectively reducing the medical burden on patients. However

this policy has had a direct impact on the cost management of private hospitals

which are for-profit enterprises. As an important part of the medical service market

the cost management of private hospitals has undergone significant changes under the impact of the "volume-based procurement" policy. This article takes Aier Eye Hospital

a leading enterprise in the private medical service industry

as the case study object. Based on the economic consequences of the implementation of the "volume-based procurement" policy and the relevant theories of cost management

it deeply analyzes the transformation of Aier Eye Hospital's cost management model

existing challenges and coping strategies under the impact of the "volume-based procurement" policy.

关键词

Keywords

references

Xu Xiaolin , Hu Liye , Guo Lequnet al . Analysis and optimization of drug use structure before and after centralized volume procurement in secondary and tertiary public hospitals [J ] . Contemporary Chinese Medicine , 2025 .

Liao Yan . Impact of National Centralized Volume-based Drug Procurement Policy on Breakthrough Innovation in Pharmaceutical Companies [D ] . Zhejiang University of Science and Technology , 2024 .

Wang Haoyang , Han Yue , Xie Jinping , et al . Research on the Impact of National Drug Centralized Volume-based Procurement and Its Follow-up Policies on Drug Consumption, Prices and Costs [J ] . China Health Economics , 2024 .

Yang G , Qian Z . Does China's centralized volume-based drug procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference model .[J ] . Frontiers in pharmacology , 2023 .

Yang Ying . Impact of China's Centralized Volume-based Drug Procurement Policy on Drug Prices and Costs from the Perspective of Strategic Purchasing [D ] . Wuhan University , 2022 .

Wei Yidan . Strategic Cost Management in Aier Eye Hospital [D ] . Guangxi University , 2022 .

Zhang Xing . Price, Behavior and Regulation: A Study on China's Centralized Volume-based Drug Procurement Policy [D ] . Northwest University , 2022 .

Li Xiaoyu . Research on the Price Mechanism of Centralized Volume-based Drug Procurement in China [D ] . Sichuan University , 2022 .

Shi Yunying . Impact of Drug Volume-based Procurement Policy [D ] . Shanghai University of Finance and Economics , 2022 .

Jing W , Ying Y , Luxinyi X , Jing W , Ying Y , Luxinyi X , et al . Impact of '4+7' volume-based drug procurement on the use of policy-related original and generic drugs: a natural experimental study in China .[J ] . BMJ open , 2022 , 12 ( 3 ).

Alert me when the article has been cited

Submit

No data

Related Author

No data

Related Institution

No data

⁰